Results 51 to 60 of about 1,366 (166)
X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation.
Macrocytic anemia with abnormal erythropoiesis is a common feature of megaloblastic anemias, congenital dyserythropoietic anemias, and myelodysplastic syndromes. Here, we characterized a family with multiple female individuals who have macrocytic anemia.
V. Sankaran +11 more
semanticscholar +1 more source
Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca2+ Signaling
ABSTRACT Objectives Antipsychotic‐induced salivary dysfunction such as hyposalivation is a prevalent clinical challenge that severely compromises oral health and quality of life. Although typical and atypical antipsychotics have their therapeutic target in the central nervous system, their direct molecular mechanisms within the salivary glands remain ...
Chaelin Chung +4 more
wiley +1 more source
Patient 3 biological passport and Expression levels of both ALAS2 LC and ALAS2 L mRNA and the mean of these expression levels in patients 1 ...
Angela Rocca (12099974) +6 more
core +1 more source
The impact of different stain carriers on the mrna profiling from bloodstains
Unlike DNA profiling, mRNA profiling is greatly affected by external factors. To analyze the influence of different stain carriers on the detectability of mRNA markers from bloodstains, this study examined 10 carriers, including a knife, cotton swab ...
Hemiao Zhao +7 more
doaj +1 more source
ABSTRACT Nutritional therapy is critical in managing inherited metabolic diseases (IMDs), and includes specialized diets and single nutritional therapy products (sNTPs) such as vitamins, cofactors, and amino acids. Many sNTPs function as medicines, but are regulated as food (e.g., food supplements), which can limit access, reimbursement, and consistent
Nina N. Stolwijk +39 more
wiley +1 more source
Table S1. Oligonucleotides primers (5Ⲡto 3 âforward) for mutagenesis and sequencing of ALAS2.
Vassili Tchaikovskii (5845703) +2 more
core +1 more source
IntroductionThe study demonstrated the feasibility of incorporating RNA biomarkers, specifically 5-aminolevulinic acid synthase (ALAS2) and carbonic anhydrase 1 (CA1), to improve the hematological module of the Athlete Biological Passport (ABP) in ...
Jessica Almeida Oliveira +10 more
doaj +1 more source
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi +3 more
wiley +1 more source
Murine ALAS2 protein schematic indicating mutated amino acid residues.
The green dotted lines represent the relative locations of the three cysteines in the HRMs of ALAS2. C11 and C38 are in the ALAS2 presequence. K313A, R433K, and the heptavariant mutations and their respective positions are indicated according to the ...
Erica J. Fratz (549421) +2 more
core +1 more source
Abstract INTRODUCTION Amyloid‐beta (Aβ)‐induced microvascular injury is a key pathological feature of cerebral amyloid angiopathy (CAA). Recent evidence suggests that ferroptosis is implicated in Aβ pathology; however, its cell‐type specificity and regulatory mechanisms within the cerebral microvasculature in CAA remain unclear. METHODS Single‐cell RNA
Chunmei Wu +9 more
wiley +1 more source

